e-learning
resources
Copenhagen 2005
Wednesday 21.09.2005
Management of tuberculosis pulmonary, extrapulmonary peculiarities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Assessment of sputum
Mycobacterium tuberculosis
messenger RNA levels in anti-microbial treatment monitoring
S. Chocholska, H. Potoczna, M. Dabrowska, R. Kieszko, A. Krol, P. Krawczyk, J. Milanowski (Lublin, Poland)
Source:
Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities
Session:
Management of tuberculosis pulmonary, extrapulmonary peculiarities
Session type:
Oral Presentation
Number:
4544
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Chocholska, H. Potoczna, M. Dabrowska, R. Kieszko, A. Krol, P. Krawczyk, J. Milanowski (Lublin, Poland). Assessment of sputum
Mycobacterium tuberculosis
messenger RNA levels in anti-microbial treatment monitoring. Eur Respir J 2005; 26: Suppl. 49, 4544
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Detection of
Mycobacterium tuberculosis
in sputum samples using polymerase chain reaction (PCR)
Source: Eur Respir J 2001; 18: Suppl. 33, 496s
Year: 2001
Detection of
Mycobacterium tuberculosis
DNA from peripheral blood in patients with HIV-seronegative and new cases of smear-positive pulmonary tuberculosis by polymerase chain reaction
Source: Eur Respir J 2002; 20: Suppl. 38, 168s
Year: 2002
Detection of isoniazid or rifampin resistant
Mycobacterium tuberculosis
in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005
Is polymerase chain reaction (PCR) an alternative for broncoscopy in patients with sputum smear negative pulmonary tuberculosis?
Source: Eur Respir J 2004; 24: Suppl. 48, 425s
Year: 2004
Evaluation of real-time polymerase chain reaction assay for the diagnosis of mycobacterium tuberculosis complex
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015
Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis
Source: Eur Respir J 2007; 30: 508-516
Year: 2007
Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis
Source: Eur Respir J 2011; 37: 376
Year: 2011
Mycobacterium tuberculosis DNA detection in urine samples from pulmonary tuberculosis patients
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008
Real time polymerase chain reaction (RT-PCR) based rapid detection of multi-drug resistant (MDR) mycobacterium tuberculosis (MTB)
Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis
Year: 2011
Diagnostic value of PCR-RT for the detection of DNA Mycobacterium tuberculosis complex (MBT) in blood from patient with pulmonary tuberculosis (PT)
Source: Annual Congress 2009 - Diagnostic advances in tuberculosis
Year: 2009
Semiquantitation of tuberculosis bacilli (MTB) and nontuberculous mycobacteria (NTM) in sputum by a new nucleic acid amplification test (NAAT)
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018
Effectiveness of real-time polymerase chain reaction for mycobacterium tuberculosis in bronchoscopic mucosal biopsy specimens for rapid diagnosis of endobronchial tuberculosis
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013
Economic evaluation of the use of PCR assay in diagnosing pulmonary TB in a low-incidence area
Source: Eur Respir J 2004; 23: 446-451
Year: 2004
Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-γ assay
Source: Eur Respir J 2007; 29: 1212-1216
Year: 2007
Diagnostic value of gastric aspirate smear and polymerase chain reaction in smear-negative pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 210s
Year: 2002
Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection
Source: Eur Respir J 2006; 28: 24-30
Year: 2006
Evaluation of PCR primers to detect mycobacterium tuberculosis complex in feces
Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR
Year: 2016
Exclusion of active Mycobacterium tuberculosis complex infection with the T-SPOTTM.TB assay
Source: Eur Respir J 2007; 29: 605-607
Year: 2007
Determination of drug susceptibility of
Mycobacterium tuberculosis
through mycolic acid analysis with HPLC technique - comparison to the conventional methods
Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities
Year: 2005
Comparative study of polymerase chain reaction for
mycobacterium tuberculosis
and conventional methods for diagnosis of tubercular pleural effusions
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept